| | CASMASCI | progen | BOC | 進口現貨產品 | 胎牛血清 | 細胞培養 | 提取試劑 | 轉染試劑 | 常規生化試劑 | ELISA試劑盒 | 抗體 | 細胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產品名稱:Irinotecan HCl trihydrate
產品貨號:LKT I6933
產品規格:10mg
Description
Irinotecan is inhibitor of the nuclear enzyme topoisomerase I, which is involved in cellular DNA replication and transcription. During replication Topoisomerase I mediates the relaxation of super coiled DNA, and it's inhibition results in breakage of the DNA chain and likely induce apoptosis. Irinotecan is therefore an attractive target for anticancer drug development. Currently it is used for the treatment of small cell lung cancer and advanced colorectal cancer.
Specifications
Cas No. 136572-09-3
Product ID I6933
Product Name Irinotecan HCl trihydrate
Chemical Name [1,4'-Bipiperidine]-1'-carboxylic acid (4S)-4,11- diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo- 1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate
Synonym Irinotecan hydrochloride trihydrate; Camptosar; Campto
Formula Wt. 677.19
Melting Point 256.5oC
Purity ≥98%
Solubility Slightly soluble in water, ethanol, chloroform.
Store Temp Ambient
References Kellner U, Rudolph P, Parwaresch R. Onkologie. 23:424-430 (2000). Kalemkerian GP, Worden FP. Expert Opin Investing Drugs. 9:565-79 (2000). Saltz LB. Curr Oncol Rep. 1:155-160 (1999).